Organigram Holdings Stock Market Value
| OGI Stock | USD 1.29 0.01 0.78% |
| Symbol | OrganiGram |
Is there potential for Pharmaceuticals market expansion? Will OrganiGram introduce new products? Factors like these will boost the valuation of OrganiGram Holdings. Anticipated expansion of OrganiGram directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.11 | Revenue Per Share | Quarterly Revenue Growth 0.487 | Return On Assets | Return On Equity |
Investors evaluate OrganiGram Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating OrganiGram Holdings' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause OrganiGram Holdings' market price to deviate significantly from intrinsic value.
It's important to distinguish between OrganiGram Holdings' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OrganiGram Holdings should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, OrganiGram Holdings' market price signifies the transaction level at which participants voluntarily complete trades.
OrganiGram Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OrganiGram Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OrganiGram Holdings.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in OrganiGram Holdings on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding OrganiGram Holdings or generate 0.0% return on investment in OrganiGram Holdings over 90 days. OrganiGram Holdings is related to or competes with Journey Medical, InfuSystems Holdings, Aurora Cannabis, Helius Medical, Cartesian Therapeutics, Orchestra BioMed, and Inventiva. Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada More
OrganiGram Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OrganiGram Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OrganiGram Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 29.65 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 7.01 |
OrganiGram Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OrganiGram Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OrganiGram Holdings' standard deviation. In reality, there are many statistical measures that can use OrganiGram Holdings historical prices to predict the future OrganiGram Holdings' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.56) |
OrganiGram Holdings February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.55) | |||
| Mean Deviation | 3.01 | |||
| Coefficient Of Variation | (1,518) | |||
| Standard Deviation | 4.29 | |||
| Variance | 18.42 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.56) | |||
| Maximum Drawdown | 29.65 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 7.01 | |||
| Skewness | 0.7581 | |||
| Kurtosis | 3.95 |
OrganiGram Holdings Backtested Returns
OrganiGram Holdings maintains Sharpe Ratio (i.e., Efficiency) of -0.0472, which implies the firm had a -0.0472 % return per unit of risk over the last 3 months. OrganiGram Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OrganiGram Holdings' Variance of 18.42, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,518) to confirm the risk estimate we provide. The company holds a Beta of 0.52, which implies possible diversification benefits within a given portfolio. As returns on the market increase, OrganiGram Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding OrganiGram Holdings is expected to be smaller as well. At this point, OrganiGram Holdings has a negative expected return of -0.21%. Please make sure to check OrganiGram Holdings' day median price, period momentum indicator, as well as the relationship between the kurtosis and maximum drawdown , to decide if OrganiGram Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.39 |
Poor reverse predictability
OrganiGram Holdings has poor reverse predictability. Overlapping area represents the amount of predictability between OrganiGram Holdings time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OrganiGram Holdings price movement. The serial correlation of -0.39 indicates that just about 39.0% of current OrganiGram Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | -0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out OrganiGram Holdings Correlation, OrganiGram Holdings Volatility and OrganiGram Holdings Performance module to complement your research on OrganiGram Holdings. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
OrganiGram Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.